LHC Group, Inc.
LHCGNASDAQHealthcare
$169.81
+$0.00(+0.00%)
Market Cap$5.3B
P/E Ratio—
52W High$169.84
52W Low$138.57
LHC Group, Inc. (LHCG) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
LHCG · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2023Report Date: Feb 22, 2023EPS Actual
$1.26
Est. $1.20 · +5.0%
Revenue
—
Est. $0.60B
Fiscal Period
Q1 FY2023
FY ends December
Report Date
Feb 22, 2023
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
LHCG reports quarterly as a NASDAQ-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▲ Q1 FY2023 | Feb 22, 2023 | $1.20 | $1.26 | +5.0% | — | $0.60B | — |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.05 | — | $0.56B | — | — |
| ▼ Q4 FY2022 | Nov 2, 2022 | $1.32 | $1.06 | -19.7% | $0.58B | — | — |
| ▼ Q3 FY2022 | Aug 3, 2022 | $1.35 | $0.98 | -27.4% | $0.58B | — | — |
| ▼ Q1 FY2022 | Feb 23, 2022 | $1.32 | $1.26 | -4.5% | $0.57B | $0.58B | -1.7% |
| — Q4 FY2021 | Dec 31, 2021 | — | $0.69 | — | $0.58B | — | — |
| ▼ Q4 FY2021 | Nov 3, 2021 | $1.51 | $1.45 | -4.0% | $0.57B | $0.58B | -2.8% |
| ▲ Q3 FY2021 | Aug 4, 2021 | $1.55 | $1.62 | +4.5% | $0.55B | $0.55B | -0.8% |
Q1 FY2023
Feb 22, 2023Beat
EPS Actual
$1.26
EPS Est.
$1.20
EPS Surpr.
+5.0%
Revenue
—
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.56B
Q4 FY2022
Nov 2, 2022Miss
EPS Actual
$1.06
EPS Est.
$1.32
EPS Surpr.
-19.7%
Revenue
$0.58B
Q3 FY2022
Aug 3, 2022Miss
EPS Actual
$0.98
EPS Est.
$1.35
EPS Surpr.
-27.4%
Revenue
$0.58B
Q1 FY2022
Feb 23, 2022Miss
EPS Actual
$1.26
EPS Est.
$1.32
EPS Surpr.
-4.5%
Revenue
$0.57B
Q4 FY2021
Dec 31, 2021
EPS Actual
$0.69
EPS Est.
—
EPS Surpr.
—
Revenue
$0.58B
Q4 FY2021
Nov 3, 2021Miss
EPS Actual
$1.45
EPS Est.
$1.51
EPS Surpr.
-4.0%
Revenue
$0.57B
Q3 FY2021
Aug 4, 2021Beat
EPS Actual
$1.62
EPS Est.
$1.55
EPS Surpr.
+4.5%
Revenue
$0.55B
No analyst estimates available for LHCG.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2023 | Feb 22, 2023 | +5.0% | $169.81 | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | $161.69 | $160.90 | -0.49% |
| ▼ Q4 FY2022 | Nov 2, 2022 | -19.7% | $167.00 | $166.08 | -0.55% |
| ▼ Q3 FY2022 | Aug 3, 2022 | -27.4% | $162.44 | $164.06 | +1.00% |
| ▼ Q1 FY2022 | Feb 23, 2022 | -4.5% | $123.90 | $120.96 | -2.37% |
| — Q4 FY2021 | Dec 31, 2021 | — | $138.61 | $137.23 | -1.00% |
| ▼ Q4 FY2021 | Nov 3, 2021 | -4.0% | $133.71 | $141.24 | +5.63% |
| ▲ Q3 FY2021 | Aug 4, 2021 | +4.5% | $214.75 | $215.29 | +0.25% |
Q1 FY2023—
Report Date
Feb 22, 2023
EPS Beat/Miss
+5.0%
Price Before
$169.81
Price After
—
Q4 FY2022-0.49%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$161.69
Price After
$160.90
Q4 FY2022-0.55%
Report Date
Nov 2, 2022
EPS Beat/Miss
-19.7%
Price Before
$167.00
Price After
$166.08
Q3 FY2022+1.00%
Report Date
Aug 3, 2022
EPS Beat/Miss
-27.4%
Price Before
$162.44
Price After
$164.06
Q1 FY2022-2.37%
Report Date
Feb 23, 2022
EPS Beat/Miss
-4.5%
Price Before
$123.90
Price After
$120.96
Q4 FY2021-1.00%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$138.61
Price After
$137.23
Q4 FY2021+5.63%
Report Date
Nov 3, 2021
EPS Beat/Miss
-4.0%
Price Before
$133.71
Price After
$141.24
Q3 FY2021+0.25%
Report Date
Aug 4, 2021
EPS Beat/Miss
+4.5%
Price Before
$214.75
Price After
$215.29
Avg Beat Reaction+0.25%
Avg Miss Reaction+0.93%
Beat Rate2 / 8 quarters
Largest Move+5.63% (Q4 FY2021)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: LHCG ends December
LHC Group, Inc. (LHCG) most recently reported earnings on February 22, 2023 for Q1 FY2023, posting EPS of $1.26 — beating the analyst consensus of $1.20 by +5.0%. The next LHCG earnings date is expected around September 1, 2026.
Each quarter, investors track LHCG earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LHCG revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
LHCG's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
LHCG earnings · 5 questionsLHC Group, Inc.'s next earnings report is expected around September 1, 2026. LHCG typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LHCG historically reports after market close (AMC).
LHCG earnings datewhen is LHCG earningsLHCG next earnings datewhen does LHCG report earningsLHCG earnings calendar
▸ Source: FMP · LHC Group, Inc. SEC filings · US GAAP · LHC Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026